Complementary 2D-PAGE and ‘shotgun’ LC–MS/MS approaches were combined to identify medium and low-abundant proteins in sera of Cystic Fibrosis (CF) patients (mild or severe pulmonary disease) in comparison with healthy CF-carrier and non-CF carrier individuals aiming to gain deeper insights into the pathogenesis of this multifactorial genetic disease. 78 differentially expressed spots were identified from 2D-PAGE proteome profiling yielding 28 identifications and postulating the existence of post-translation modifications (PTM). The ‘shotgun’ approach highlighted altered levels of proteins actively involved in CF: abnormal tissue/airway remodeling, protease/antiprotease imbalance, innate immune dysfunction, chronic inflammation, nutrit...
Cystic fibrosis (CF) is a hereditary disease caused by mutations in the CF transmembrane conductance...
Hallmarks of cystic fibrosis (CF) are increased viscosity of mucus and impaired mucociliary clearanc...
Background and Aims: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30 % ...
Complementary 2D-PAGE and ‘shotgun’ LC–MS/MS approaches were combined to identify medium and low-abu...
ABSTRACT: The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residu...
The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residue at posit...
The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residue at posit...
Cystic fibrosis (CF) is a congenital disease that results in great morbidity and mortality mainly in...
AbstractNumerous factors, other than mutations in the CFTR gene, affect the phenotypic variability o...
BackgroundProteomics can reveal molecular pathways of disease and provide translational perspectives...
Cystic Fibrosis (CF) is a recessively inherited disease caused by mutations in the Cystic Fibrosis T...
The pathophysiology of cystic fibrosis (CF) lung disease remains incompletely understood. New explan...
International audienceThe pathophysiology of cystic fibrosis (CF) lung disease remains incompletely ...
Tese de doutoramento em Biologia (Biologia Molecular), apresentada à Universidade de Lisboa através ...
Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and involves chro...
Cystic fibrosis (CF) is a hereditary disease caused by mutations in the CF transmembrane conductance...
Hallmarks of cystic fibrosis (CF) are increased viscosity of mucus and impaired mucociliary clearanc...
Background and Aims: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30 % ...
Complementary 2D-PAGE and ‘shotgun’ LC–MS/MS approaches were combined to identify medium and low-abu...
ABSTRACT: The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residu...
The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residue at posit...
The most prevalent cause of cystic fibrosis (CF) is the deletion of a phenylalanine residue at posit...
Cystic fibrosis (CF) is a congenital disease that results in great morbidity and mortality mainly in...
AbstractNumerous factors, other than mutations in the CFTR gene, affect the phenotypic variability o...
BackgroundProteomics can reveal molecular pathways of disease and provide translational perspectives...
Cystic Fibrosis (CF) is a recessively inherited disease caused by mutations in the Cystic Fibrosis T...
The pathophysiology of cystic fibrosis (CF) lung disease remains incompletely understood. New explan...
International audienceThe pathophysiology of cystic fibrosis (CF) lung disease remains incompletely ...
Tese de doutoramento em Biologia (Biologia Molecular), apresentada à Universidade de Lisboa através ...
Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and involves chro...
Cystic fibrosis (CF) is a hereditary disease caused by mutations in the CF transmembrane conductance...
Hallmarks of cystic fibrosis (CF) are increased viscosity of mucus and impaired mucociliary clearanc...
Background and Aims: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30 % ...